PBI-MST-01 (NCT04541108) Substudy AZN-05: Intratumoral Microdosing of Rilvegostomig, Volrustomig, Sabestomig, and AZD9592 in HNSCC

Clinical trial NCT06366451 · COMPLETED

Trial details

NCT number: NCT06366451
Sponsor: Presage Biosciences
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma

Start date: 2024-05-22
Primary completion: 2026-03-25
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.